Literature DB >> 11533634

Putting a price on biotechnology.

J J Stewart1, P N Allison, R S Johnson.   

Abstract

Mesh：

Year:  2001        PMID： 11533634     DOI： 10.1038/nbt0901-813

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  The critical impact of time discounting on economic incentives to overcome the antibiotic market failure.

Authors:  Brad Spellberg; Priya Sharma; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

Review 2.  Challenges in the transition to model-based development.

Authors:  Thaddeus H Grasela; Jill Fiedler-Kelly; Cynthia A Walawander; Joel S Owen; Brenda B Cirincione; Kathleen E Reitz; Elizabeth A Ludwig; Julie A Passarell; Charles W Dement
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

3.  Pharmaceutical patent evaluation and licensing using a stochastic model and Monte Carlo simulations.

Authors:  Liangchuan Wu; Lianghong Wu
Journal:  Nat Biotechnol       Date:  2011-09-08       Impact factor: 54.908

4.  On the horizon-the value and promise of the global pipeline of Alzheimer's disease therapeutics.

Authors:  Michael A Cole; Guy R Seabrook
Journal:  Alzheimers Dement (N Y)       Date:  2020-05-12

5.  Value drivers of development stage biopharma companies.

Authors:  Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal:  Eur J Health Econ       Date:  2022-01-17

6.  Net present value approaches for drug discovery.

Authors:  Andreas M Svennebring; Jarl Es Wikberg
Journal:  Springerplus       Date:  2013-04-01

Review 7.  Determining quantitative targets for public funding of tuberculosis research and development.

Authors:  David R Walwyn
Journal:  Health Res Policy Syst       Date:  2013-03-08

Review 8.  Applications of genetically modified tools to safety assessment in drug development.

Authors:  Hee Yeon Kay; Hongmin Wu; Seo In Lee; Sang Geon Kim
Journal:  Toxicol Res       Date:  2010-03

Review 9.  New business models for antibiotic innovation.

Authors:  Anthony D So; Tejen A Shah
Journal:  Ups J Med Sci       Date:  2014-03-19       Impact factor: 2.384

Review 10.  Improving target assessment in biomedical research: the GOT-IT recommendations.

Authors:  Christoph H Emmerich; Lorena Martinez Gamboa; Martine C J Hofmann; Marc Bonin-Andresen; Olga Arbach; Pascal Schendel; Björn Gerlach; Katja Hempel; Anton Bespalov; Ulrich Dirnagl; Michael J Parnham
Journal:  Nat Rev Drug Discov       Date:  2020-11-16       Impact factor: 112.288
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.